Literature DB >> 29932243

Improving outcomes in gestational diabetes: does gestational weight gain matter?

C E M Aiken1,2, L Hone2, H R Murphy3,4, C L Meek3,5,6,7.   

Abstract

AIM: Excessive gestational weight gain increases risk of gestational diabetes mellitus (GDM) but it remains unclear whether weight control after GDM diagnosis improves outcomes. We assessed whether: (1) total gestational weight gain during pregnancy (0-36 weeks); (2) early gestational weight gain (0-28 weeks, before GDM diagnosis); or (3) late gestational weight gain (28-36 weeks, after diagnosis) are associated with maternal-fetal outcomes.
METHODS: Some 546 women with GDM who delivered viable singleton infants at a single UK obstetric centre (October 2014 to March 2017) were included in this retrospective observational study.
RESULTS: Higher total gestational weight gain was associated with Caesarean section [n = 376; odds ratio (OR) 1.05; confidence intervals (CI) 1.02-1.08, P < 0.001] and large for gestational age (OR 1.08; CI 1.03-1.12, P < 0.001). Higher late gestational weight gain (28-36 weeks; n = 144) was associated with large for gestational age (OR 1.17; CI 1.01-1.37, P < 0.05), instrumental deliveries (OR 1.26; CI 1.03-1.55, P < 0.01), higher total daily insulin doses (36 weeks; beta coefficient 4.37; CI 1.92-6.82, P < 0.001), and higher post-partum 2-h oral glucose tolerance test concentrations (beta coefficient 0.12; CI 0.01-0.22, P < 0.05). Women who avoided substantial weight gain after GDM diagnosis had 0.7 mmol/l lower postnatal 2-h glucose and needed half the amount of insulin/day at 36 weeks compared with women with substantial weight gain after diagnosis. There were no significant associations between early gestational weight gain (0-28 weeks) and pregnancy outcomes.
CONCLUSIONS: These findings suggest that controlling gestational weight gain should be a priority following GDM diagnosis to optimize pregnancy outcomes and improve maternal postnatal glucose homeostasis. The period after diagnosis of GDM (often 28 weeks gestation) is not too late to offer lifestyle advice or intervention to improve weight management and pregnancy outcomes.
© 2018 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29932243     DOI: 10.1111/dme.13767

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  10 in total

1.  The association between longer durations of the latent phase of labor and subsequent perinatal processes and outcomes among midwifery patients.

Authors:  Ellen L Tilden; Julia C Phillippi; Nicole Carlson; Mekhala Dissanayake; Christopher S Lee; Aaron B Caughey; Jonathan M Snowden
Journal:  Birth       Date:  2020-07-20       Impact factor: 3.689

2.  Potentially modifiable predictors of adverse neonatal and maternal outcomes in pregnancies with gestational diabetes mellitus: can they help for future risk stratification and risk-adapted patient care?

Authors:  Maria-Christina Antoniou; Leah Gilbert; Justine Gross; Jean-Benoît Rossel; Céline J Fischer Fumeaux; Yvan Vial; Jardena J Puder
Journal:  BMC Pregnancy Childbirth       Date:  2019-12-04       Impact factor: 3.007

3.  Relative Contribution of Gestational Weight Gain, Gestational Diabetes, and Maternal Obesity to Neonatal Fat Mass.

Authors:  Delphine Mitanchez; Sophie Jacqueminet; Said Lebbah; Marc Dommergues; David Hajage; Cécile Ciangura
Journal:  Nutrients       Date:  2020-11-09       Impact factor: 5.717

4.  Contributing Factors to Perinatal Outcome in Pregnancies with Gestational Diabetes-What Matters Most? A Retrospective Analysis.

Authors:  Friederike Weschenfelder; Friederike Hein; Thomas Lehmann; Ekkehard Schleußner; Tanja Groten
Journal:  J Clin Med       Date:  2021-01-18       Impact factor: 4.241

5.  Impact of metformin treatment during pregnancy on maternal outcomes: a systematic review/meta-analysis.

Authors:  Jane L Tarry-Adkins; Susan E Ozanne; Catherine E Aiken
Journal:  Sci Rep       Date:  2021-04-29       Impact factor: 4.379

6.  Plasma-glycated CD59 as an early biomarker for gestational diabetes mellitus: prospective cohort study protocol.

Authors:  Chloe Andrews; Michelle Toth-Castillo; Huseyin Aktas; Miguel-Angel Luque Fernandez; Steven Koon Wong; Sarbattama Sen; Jose Halperin
Journal:  BMJ Open       Date:  2022-04-20       Impact factor: 3.006

7.  Dietary Intervention in Pregnant Women with Gestational Diabetes; Protocol for the DiGest Randomised Controlled Trial.

Authors:  Laura C Kusinski; Helen R Murphy; Emanuella De Lucia Rolfe; Kirsten L Rennie; Linda M Oude Griep; Deborah Hughes; Roy Taylor; Claire L Meek
Journal:  Nutrients       Date:  2020-04-22       Impact factor: 5.717

8.  Approaches to screening for hyperglycaemia in pregnant women during and after the COVID-19 pandemic.

Authors:  C L Meek; R S Lindsay; E M Scott; C E Aiken; J Myers; R M Reynolds; D Simmons; J M Yamamoto; D R McCance; H R Murphy
Journal:  Diabet Med       Date:  2020-09-21       Impact factor: 4.359

9.  Seasonal variations in incidence and maternal-fetal outcomes of gestational diabetes.

Authors:  C L Meek; B Devoy; D Simmons; C J Patient; A R Aiken; H R Murphy; C E Aiken
Journal:  Diabet Med       Date:  2020-02-05       Impact factor: 4.213

10.  Antenatal Determinants of Childhood Obesity in High-Risk Offspring: Protocol for the DiGest Follow-Up Study.

Authors:  Danielle Jones; Emanuella De Lucia Rolfe; Kirsten L Rennie; Linda M Oude Griep; Laura C Kusinski; Deborah J Hughes; Soren Brage; Ken K Ong; Kathryn Beardsall; Claire L Meek
Journal:  Nutrients       Date:  2021-03-31       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.